US › Healthcare

Quantum BioPharma Ltd. (QNTM)

US · Healthcare · Biotechnology

$2.87-5.90%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-13.4M

Profit YoY

-55.9%

EPS

$-4.17

EPS estimate

$-0.68

EPS came in at -4.17 against a street estimate of -0.68 — a miss of 513.2%.

Key statistics

Market cap

$18.5M

Forward P/E

0.0

P/B

31.28

Book value

$0.10

EPS (TTM)

$-7.73

52-week high

$31.91

52-week low

$2.07

50-day MA

$4.17

200-day MA

$5.93

Beta

0.44

Analyst view

with an average price target of $12.43.

Shareholding

Insiders

12.36%

Institutions

11.46%

Largest institutional holders

Fund	Stake
AdvisorShares Investments, LLC	1.70%
Platform Technology Partners	0.64%
Jane Street Group LLC	0.49%
Citadel Advisors Llc	0.25%
Marex Group Ltd	0.21%
Virtu Financial LLC	0.19%
Mariner Wealth Advisors LLC	0.16%
UBS Group AG	0.11%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Quantum BioPharma Ltd. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.